Browsing: responses

Patients with resectable stage II–IIIB non-small cell lung cancer (NSCLC) treated with perioperative atezolizumab plus platinum-based chemotherapy experienced a median…

Adelaide University researchers have developed a new way of using mRNA technology to reprogram tumor-supporting immune cells and strengthen the…

Influenza remains a major global health challenge as continual antigenic drift can limit the breadth and durability of vaccine-induced antibody…

A team led by investigators from the University of Osaka uncovers cellular mechanisms that favor long-lived antibody responses, providing insights…

Patients’ responses to questions routinely raised by oncologists may provide important clues about their chances of survival from chronic lymphocytic…